Home/Filings/4/0001209191-14-078273
4//SEC Filing

Adamas Pharmaceuticals Inc 4

Accession 0001209191-14-078273

CIK 0001328143operating

Filed

Dec 28, 7:00 PM ET

Accepted

Dec 29, 7:40 PM ET

Size

8.3 KB

Accession

0001209191-14-078273

Insider Transaction Report

Form 4
Period: 2014-12-24
Transactions
  • Sale

    Common Stock

    2014-12-24$17.51/sh2,000$35,02051,778 total
Footnotes (1)
  • [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

Issuer

Adamas Pharmaceuticals Inc

CIK 0001328143

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001328143

Filing Metadata

Form type
4
Filed
Dec 28, 7:00 PM ET
Accepted
Dec 29, 7:40 PM ET
Size
8.3 KB